Otizm Spektrum Bozukluğunda Genetik ve Moleküler Temelli Tedavi Yaklaşımları

Belenska-Todorova L, Zamfirov M, Todorov T, Atemin S, Sleptsova M, Pavlova Z, Kadiyska T, Maver A, Peterlin B, Todorova A. Exome Study of Single Nucleotide Variations in Patients with Syndromic and Non-Syndromic Autism Reveals Potential Candidate Genes for Diagnostics and Novel Single Nucleotide Variants. Cells. 2025 Jun 17;14(12):915. doi: 10.3390/cells14120915. PMID: 40558542; PMCID: PMC12191266.

Sandhu A, Kumar A, Rawat K, Gautam V, Sharma A, Saha L. Modernising autism spectrum disorder model engineering and treatment via CRISPR-Cas9: A gene reprogramming approach. World J Clin Cases. 2023 May 16;11(14):3114-3127. doi: 10.12998/wjcc.v11.i14.3114. PMID: 37274051; PMCID: PMC10237133.

Roberts JE, Bradshaw J, Will E, Hogan AL, McQuillin S, Hills K. Emergence and rate of autism in fragile X syndrome across the first years of life. Dev Psychopathol. 2020 Oct;32(4):1335-1352. doi: 10.1017/S0954579420000942. PMID: 33161907; PMCID: PMC8080303.

Percy AK. Rett syndrome: exploring the autism link. Arch Neurol. 2011 Aug;68(8):985- 9. doi: 10.1001/archneurol.2011.149. PMID: 21825235; PMCID: PMC3674963.

Hunt A, Shepherd C. A prevalence study of autism in tuberous sclerosis. J Autism Dev Disord. 1993 Jun;23(2):323-39. doi: 10.1007/BF01046223. PMID: 8331050.

Dias C, Mo A, Cai C, Sun L, Cabral K, Brownstein CA, Rockowitz S, Walsh CA. Cell- type-specific effects of autism-associated 15q duplication syndrome in the human brain. Am J Hum Genet. 2024 Aug 8;111(8):1544-1558. doi: 10.1016/j.ajhg.2024.07.002. Epub 2024 Jul 29. PMID: 39079538; PMCID: PMC11339625.

Phelan K, Rogers RC, Boccuto L. Phelan-McDermid Syndrome-SHANK3 Related. 2005 May 11 [Updated 2024 Jun 6]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. Available from: https://www.ncbi.nlm.nih.gov/sites/books/NBK1198/?utm_source=chatgpt.com

Richards C, Jones C, Groves L, Moss J, Oliver C. Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2015 Oct;2(10):909-16. doi: 10.1016/S2215-0366(15)00376-4. Epub 2015 Sep 1. PMID: 26341300.

Apte M, Kumar A. Correlation of mutated gene and signalling pathways in ASD. IBRO Neurosci Rep. 2023 Mar 27;14:384-392. doi: 10.1016/j.ibneur.2023.03.011. PMID: 37101819; PMCID: PMC10123338.

Zhang Y, Tang R, Hu ZM, Wang XH, Gao X, Wang T, Tang MX. Key Synaptic Pathology in Autism Spectrum Disorder: Genetic Mechanisms and Recent Advances. J Integr Neurosci. 2024 Sep 29;23(10):184. doi: 10.31083/j.jin2310184. PMID: 39473158.

Vyas Y, Cheyne J, Lee K, Jung Y, Montgomery JM. Shankopathies in the developing brain in autism spectrum disorders. Front Neurosci. 2021;15:775431. doi:10.3389/fnins.2021.775431

Bernier R, Golzio C, Xiong B, Stessman HA, Coe BP, Penn O, Witherspoon K, Gerdts J, Baker C, Vulto-van Silfhout AT, Schuurs-Hoeijmakers JH, Fichera M, Bosco P, Buono S, Alberti A, Failla P, Peeters H, Steyaert J, Vissers LELM, Francescatto L, Mefford HC, Rosenfeld JA, Bakken T, O'Roak BJ, Pawlus M, Moon R, Shendure J, Amaral DG, Lein E, Rankin J, Romano C, de Vries BBA, Katsanis N, Eichler EE. Disruptive CHD8 mutations define a subtype of autism early in development. Cell. 2014 Jul 17;158(2):263-276. doi: 10.1016/j.cell.2014.06.017. Epub 2014 Jul 3. PMID: 24998929; PMCID: PMC4136921.

Holder JL Jr, Hamdan FF, Michaud JL. SYNGAP1-Related Intellectual Disability. 2019 Feb 21. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537721/

Leblond CS, Le TL, Malesys S, Cliquet F, Tabet AC, Delorme R, Rolland T, Bourgeron

T. Operative list of genes associated with autism and neurodevelopmental disorders based on database review. Mol Cell Neurosci. 2021 Jun;113:103623. doi: 10.1016/j.mcn.2021.103623. Epub 2021 Apr 29. PMID: 33932580.

Wang T, Kim CN, Bakken TE, Gillentine MA, Henning B, Mao Y, Gilissen C; SPARK Consortium; Nowakowski TJ, Eichler EE. Integrated gene analyses of de novo variants from 46,612 trios with autism and developmental disorders. Proc Natl Acad Sci U S A. 2022 Nov 15;119(46):e2203491119. doi: 10.1073/pnas.2203491119. Epub 2022 Nov 9. PMID: 36350923; PMCID: PMC9674258.

Kereszturi É. Diversity and Classification of Genetic Variations in Autism Spectrum Disorder. Int J Mol Sci. 2023 Nov 26;24(23):16768. doi: 10.3390/ijms242316768. PMID: 38069091; PMCID: PMC10706722.

Rolland T, Cliquet F, Anney RJL, Moreau C, Traut N, Mathieu A, Huguet G, Duan J, Warrier V, Portalier S, Dry L, Leblond CS, Douard E, Amsellem F, Malesys S, Maruani A, Toro R, Børglum AD, Grove J, Baron-Cohen S, Packer A, Chung WK, Jacquemont S, Delorme R, Bourgeron T. Phenotypic effects of genetic variants associated with autism. Nat Med. 2023 Jul;29(7):1671-1680. doi: 10.1038/s41591-023-02408-2. Epub 2023 Jun 26. PMID: 37365347; PMCID: PMC10353945.

Dong ZF, Tang LJ, Deng GF, Zeng T, Liu SJ, Wan RP, Liu T, Zhao QH, Yi YH, Liao WP, Long YS. Transcription of the human sodium channel SCN1A gene is repressed by a scaffolding protein RACK1. Mol Neurobiol. 2014 Oct;50(2):438-48. doi: 10.1007/s12035-014-8633-9. Epub 2014 Jan 17. PMID: 24436055.

Ghanbarian H, Aghamiri S, Eftekhary M, Wagner N, Wagner KD. Small Activating RNAs: Towards the Development of New Therapeutic Agents and Clinical Treatments. Cells. 2021 Mar 8;10(3):591. doi: 10.3390/cells10030591. PMID: 33800164; PMCID: PMC8001863.

Zhang Y, Zhang XO, Chen T, Xiang JF, Yin QF, Xing YH, Zhu S, Yang L, Chen LL. Circular intronic long noncoding RNAs. Mol Cell. 2013 Sep 26;51(6):792-806. doi: 10.1016/j.molcel.2013.08.017. Epub 2013 Sep 12. PMID: 24035497.

Di Leva F, Arnoldi M, Santarelli S, Massonot M, Lemée MV, Bon C, Pellegrini M, Castellini ME, Zarantonello G, Messina A, Bozzi Y, Bernier R, Zucchelli S, Casarosa S, Dassi E, Ronzitti G, Golzio C, Morandell J, Gustincich S, Espinoza S, Biagioli M.

SINEUP RNA rescues molecular phenotypes associated with CHD8 suppression in autism spectrum disorder model systems. Mol Ther. 2025 Mar 5;33(3):1180-1196. doi: 10.1016/j.ymthe.2024.12.043. Epub 2024 Dec 30. PMID: 39741407; PMCID: PMC11897779.

Wijnant KN, Nadif Kasri N, Vissers LELM. Systematic analysis of genetic and phenotypic characteristics reveals antisense oligonucleotide therapy potential for one- third of neurodevelopmental disorders. Genome Med. 2025 May 21;17(1):59. doi: 10.1186/s13073-025-01477-x. PMID: 40400017; PMCID: PMC12096787.

Tran SS, Jun HI, Bahn JH, Azghadi A, Ramaswami G, Van Nostrand EL, Nguyen TB, Hsiao YE, Lee C, Pratt GA, Martínez-Cerdeño V, Hagerman RJ, Yeo GW, Geschwind DH, Xiao X. Widespread RNA editing dysregulation in brains from autistic individuals. Nat Neurosci. 2019 Jan;22(1):25-36. doi: 10.1038/s41593-018-0287-x. Epub 2018 Dec 17. PMID: 30559470; PMCID: PMC6375307.

Sinnamon JR, Kim SY, Fisk JR, Song Z, Nakai H, Jeng S, McWeeney SK, Mandel G. In Vivo Repair of a Protein Underlying a Neurological Disorder by Programmable RNA Editing. Cell Rep. 2020 Jul 14;32(2):107878. doi: 10.1016/j.celrep.2020.107878. PMID: 32668243; PMCID: PMC7449137.

Bajikar SS, Sztainberg Y, Trostle AJ, Tirumala HP, Wan YW, Harrop CL, Bengtsson JD, Carvalho CMB, Pehlivan D, Suter B, Neul JL, Liu Z, Jafar-Nejad P, Rigo F, Zoghbi HY. Modeling antisense oligonucleotide therapy in MeCP2 duplication syndrome human iPSC-derived neurons reveals gene expression programs responsive to MeCP2 levels. Hum Mol Genet. 2024 Nov 8;33(22):1986-2001. doi: 10.1093/hmg/ddae135. PMID: 39277796; PMCID: PMC11555823

Shao Y, Sztainberg Y, Wang Q, Bajikar SS, Trostle AJ, Wan YW, Jafar-Nejad P, Rigo F, Liu Z, Tang J, Zoghbi HY. Antisense oligonucleotide therapy in a humanized mouse model of MeCP2 duplication syndrome. Sci Transl Med. 2021 Mar 3;13(583):eaaz7785. doi: 10.1126/scitranslmed.aaz7785. PMID: 33658357; PMCID: PMC8976688.

Batty P, Lillicrap D. Adeno-associated viral vector integration: implications for long- term efficacy and safety. J Thromb Haemost. 2024 Nov;22(11):2945-2960. doi: 10.1016/j.jtha.2024.07.012. Epub 2024 Aug 2. PMID: 39097231.

Muhuri M, Levy DI, Schulz M, McCarty D, Gao G. Durability of transgene expression after rAAV gene therapy. Mol Ther. 2022 Apr 6;30(4):1364-1380. doi: 10.1016/j.ymthe.2022.03.004. Epub 2022 Mar 10. PMID: 35283274; PMCID: PMC9077371.

Meng L, Ward AJ, Chun S, Bennett CF, Beaudet AL, Rigo F. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Nature. 2015 Feb 19;518(7539):409-12. doi: 10.1038/nature13975. Epub 2014 Dec 1. PMID: 25470045; PMCID: PMC4351819.

https://www.businesswire.com/news/home/20250611150485/en/First-patient-dosed- in-pivotal-Phase-3-REVEAL-clinical-study-of-ION582-in-Angelman-syndrome

Shah S, Sharp KJ, Raju Ponny S, Lee J, Watts JK, Berry-Kravis E, Richter JD. Antisense oligonucleotide rescue of CGG expansion-dependent FMR1 mis-splicing in fragile X syndrome restores FMRP. Proc Natl Acad Sci U S A. 2023 Jul 4;120(27):e2302534120.

doi: 10.1073/pnas.2302534120. Epub 2023 Jun 26. PMID: 37364131; PMCID: PMC10319035)

https://dupmecp2.eu/en/attune-recruitment/

Han Z, Chen C, Christiansen A, Ji S, Lin Q, Anumonwo C, Liu C, Leiser SC, Meena, Aznarez I, Liau G, Isom LL. Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome. Sci Transl Med. 2020 Aug 26;12(558):eaaz6100. doi: 10.1126/scitranslmed.aaz6100. PMID: 32848094.

Lim KH, Han Z, Jeon HY, Kach J, Jing E, Weyn-Vanhentenryck S, Downs M, Corrionero A, Oh R, Scharner J, Venkatesh A, Ji S, Liau G, Ticho B, Nash H, Aznarez

Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression. Nat Commun. 2020 Jul 9;11(1):3501. doi: 10.1038/s41467-020-17093-9. PMID: 32647108; PMCID: PMC7347940.

https://aesnet.org/abstractslisting/zorevunersen-stk-001-demonstrates-potential-for- disease-modification-including-reductions-in-seizures-and-improvements-in- cognition-and-behavior-in-children-and-adolescents-with-dravet-syndrome-ds

Kantor A, McClements ME, MacLaren RE. CRISPR-Cas9 DNA Base-Editing and Prime-Editing. Int J Mol Sci. 2020 Aug 28;21(17):6240. doi: 10.3390/ijms21176240. PMID: 32872311; PMCID: PMC7503568.

Weuring W, Geerligs J, Koeleman BPC. Gene Therapies for Monogenic Autism Spectrum Disorders. Genes (Basel). 2021 Oct 22;12(11):1667. doi: 10.3390/genes12111667. PMID: 34828273; PMCID: PMC8617899.

Bozorg Qomi S, Asghari A, Mojarrad M. An Overview of the CRISPR-Based Genomic- and Epigenome-Editing System: Function, Applications, and Challenges. Adv Biomed Res. 2019 Aug 21;8:49. doi: 10.4103/abr.abr_41_19. PMID: 31516887; PMCID: PMC6712897.

Zheng Y, Li Y, Zhou K, Li T, VanDusen NJ, Hua Y. Precise genome-editing in human diseases: mechanisms, strategies and applications. Signal Transduct Target Ther. 2024 Feb 26;9(1):47. doi: 10.1038/s41392-024-01750-2. PMID: 38409199; PMCID: PMC10897424.

Ozlu C, Bailey RM, Sinnett S, Goodspeed KD. Gene Transfer Therapy for Neurodevelopmental Disorders. Dev Neurosci. 2021;43(3-4):230-240. doi: 10.1159/000515434. Epub 2021 Apr 21. PMID: 33882495.

Adhikari A, Copping NA, Beegle J, Cameron DL, Deng P, O'Geen H, Segal DJ, Fink KD, Silverman JL, Anderson JS. Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells. Hum Mol Genet. 2021 Jun 9;30(12):1067-1083. doi: 10.1093/hmg/ddab104. PMID: 33856035; PMCID: PMC8188406.

Delling JP, Boeckers TM. Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications. J Neurodev Disord. 2021 Nov 16;13(1):55. doi: 10.1186/s11689-021-09397-8. PMID: 34784886; PMCID: PMC8594088.

https://patentscope.wipo.int/search/en/WO2024178401

Veenstra-VanderWeele J, O'Reilly KC, Dennis MY, Uribe-Salazar JM, Amaral DG. Translational Neuroscience Approaches to Understanding Autism. Am J Psychiatry. 2023 Apr 1;180(4):265-276. doi: 10.1176/appi.ajp.20230153. PMID: 37002692.

Liu XS, Wu H, Krzisch M, Wu X, Graef J, Muffat J, Hnisz D, Li CH, Yuan B, Xu C, Li Y, Vershkov D, Cacace A, Young RA, Jaenisch R. Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene. Cell. 2018 Feb 22;172(5):979-992.e6. doi: 10.1016/j.cell.2018.01.012. Epub 2018 Feb 15. PMID: 29456084; PMCID: PMC6375087.

Colasante G, Lignani G, Brusco S, Di Berardino C, Carpenter J, Giannelli S, Valassina N, Bido S, Ricci R, Castoldi V, Marenna S, Church T, Massimino L, Morabito G, Benfenati F, Schorge S, Leocani L, Kullmann DM, Broccoli V. dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice. Mol Ther. 2020 Jan 8;28(1):235-253. doi: 10.1016/j.ymthe.2019.08.018. Epub 2019 Sep 3. PMID: 31607539; PMCID: PMC6952031)

Gholamalizadeh H, Amiri-Shahri M, Rasouli F, Ansari A, Baradaran Rahimi V, Reza Askari V. DNA Methylation in Autism Spectrum Disorders: Biomarker or Pharmacological Target? Brain Sci. 2024 Jul 23;14(8):737. doi: 10.3390/brainsci14080737. PMID: 39199432; PMCID: PMC11352561.

Zhubi A, Cook EH, Guidotti A, Grayson DR. Epigenetic mechanisms in autism spectrum disorder. Int Rev Neurobiol. 2014;115:203-44. doi: 10.1016/B978-0-12- 801311-3.00006-8. PMID: 25131546.

Levenson JM, Roth TL, Lubin FD, Miller CA, Huang IC, Desai P, Malone LM, Sweatt JD. Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J Biol Chem. 2006 Jun 9;281(23):15763-73. doi: 10.1074/jbc.M511767200. Epub 2006 Apr 10. PMID: 16606618.

Matt SM, Zimmerman JD, Lawson MA, Bustamante AC, Uddin M, Johnson RW. Inhibition of DNA Methylation With Zebularine Alters Lipopolysaccharide-Induced Sickness Behavior and Neuroinflammation in Mice. Front Neurosci. 2018 Sep 18;12:636. doi: 10.3389/fnins.2018.00636. PMID: 30279646; PMCID: PMC6153314.

Gao Y, Aljazi MB, Wu Y, He J. Vorinostat, a histone deacetylase inhibitor, ameliorates the sociability and cognitive memory in an Ash1L-deletion-induced ASD/ID mouse model. Neurosci Lett. 2021 Nov 1;764:136241. doi: 10.1016/j.neulet.2021.13624. Epub 2021 Sep 10. PMID: 34509565; PMCID: PMC8572157.

Chen E, Schmitt J, McIntosh G, Young BP, Lian T, Liu J, Chen KK, Liston JB, MacDonald L, Wang B, Medina Giro S, Boehme B, Das M, Indran S, Chao JT, Rogic S, Pavlidis P, Allan DW, Loewen CJR. Revealing function-altering MeCP2 mutations in individuals with autism spectrum disorder using yeast and Drosophila. Genetics. 2025 Jun 23:iyaf121. doi: 10.1093/genetics/iyaf121. Epub ahead of print. PMID: 40546018.

Kumar V, Kundu S, Singh A, Singh S. Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective. Curr Neuropharmacol. 2022;20(1):158-178. doi: 10.2174/1570159X19666210609160017. PMID: 34151764; PMCID: PMC9199543.

Awamleh Z, Choufani S, Wu W, Rots D, Dingemans AJM, Nadif Kasri N, Boronat S, Ibañez-Mico S, Cuesta Herraiz L, Ferrer I, Martínez Carrascal A, Pérez-Jurado LA, Aznar Lain G, Ortigoza-Escobar JD, de Vries BBA, Koolen DA, Weksberg R. A new blood DNA methylation signature for Koolen-de Vries syndrome: Classification of missense KANSL1 variants and comparison to fibroblast cells. Eur J Hum Genet. 2024 Mar;32(3):324-332. doi: 10.1038/s41431-024-01538-6. Epub 2024 Jan 29. Erratum in: Eur J Hum Genet. 2024 Mar;32(3):366. doi: 10.1038/s41431-024-01561-7. PMID: 38282074; PMCID: PMC10923882.

https://omim- org.translate.goog/entry/615873?_x_tr_sl=en&_x_tr_tl=tr&_x_tr_hl=tr&_x_tr_pto=tc

Coffee B, Zhang F, Ceman S, Warren ST, Reines D. Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Am J Hum Genet. 2002 Oct;71(4):923-32. doi: 10.1086/342931. Epub 2002 Sep 13. PMID: 12232854; PMCID: PMC378545.

Lui JC, Baron J. Epigenetic Causes of Overgrowth Syndromes. J Clin Endocrinol Metab. 2024 Jan 18;109(2):312-320. doi: 10.1210/clinem/dgad420. PMID: 37450557; PMCID: PMC11032252.

Li X, Zhang Y, Wang L, Lin Y, Gao Z, Zhan X, Huang Y, Sun C, Wang D, Liang S, Wu L. Integrated Analysis of Brain Transcriptome Reveals Convergent Molecular Pathways in Autism Spectrum Disorder. Front Psychiatry. 2019 Oct 8;10:706. doi: 10.3389/fpsyt.2019.00706. PMID: 31649562; PMCID: PMC6795181.

Sugathan A, Biagioli M, Golzio C, Erdin S, Blumenthal I, Manavalan P, Ragavendran A, Brand H, Lucente D, Miles J, Sheridan SD, Stortchevoi A, Kellis M, Haggarty SJ, Katsanis N, Gusella JF, Talkowski ME. CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors. Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4468-77. doi: 10.1073/pnas.1405266111. Epub 2014 Oct 7. PMID: 25294932; PMCID: PMC4210312.

Xu Q, Liu YY, Wang X, Tan GH, Li HP, Hulbert SW, Li CY, Hu CC, Xiong ZQ, Xu X, Jiang YH. Autism-associated CHD8 deficiency impairs axon development and migration of cortical neurons. Mol Autism. 2018 Dec 19;9:65. doi: 10.1186/s13229- 018-0244-2. PMID: 30574290; PMCID: PMC6299922.

Weissberg O, Elliott E. The Mechanisms of CHD8 in Neurodevelopment and Autism Spectrum Disorders. Genes (Basel). 2021 Jul 26;12(8):1133. doi: 10.3390/genes12081133. PMID: 34440307; PMCID: PMC8393912.

Wells C, Sorgenfrei J, Johnson SL, Albertson D, Rutter J, Baker SA. Gene delivery of AGAT and GAMT boosts creatine levels in creatine transporter deficiency patient fibroblasts. PLoS One. 2025 May 8;20(5):e0319350. doi: 10.1371/journal.pone.0319350. PMID: 40338959; PMCID: PMC12061113.

Baker SA, Gajera CR, Wawro AM, Corces MR, Montine TJ. GATM and GAMT synthesize creatine locally throughout the mammalian body and within oligodendrocytes of the brain. Brain Res. 2021 Nov 1;1770:147627. doi: 10.1016/j.brainres.2021.147627. Epub 2021 Aug 19. PMID: 34418357.

Jerow LG, Krueger DA, Gross C, Danzer SC. Somatic mosaicism and interneuron involvement in mTORopathies. Trends Neurosci. 2025 May;48(5):362-376. doi:

10.1016/j.tins.2025.02.009. Epub 2025 Mar 22. PMID: 40121168; PMCID: PMC12078011.

Hwang SK, Lee JH, Yang JE, Lim CS, Lee JA, Lee YS, Lee K, Kaang BK. Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation. Mol Brain. 2016 May 23;9(1):56. doi: 10.1186/s13041-016- 0222-6. PMID: 27216612; PMCID: PMC4878062.

https://clinicaltrials.gov/study/NCT01929642?term=AREA%5BBasicSearch%5D(AR EA%5BConditionSearch%5D(%22Tuberous%20Sclerosis%22)%20AND%20AREA

%5BInterventionSearch%5D(%22MTOR%20Inhibitors%22))&rank=6

Hu LY, Shi XY, Yang XF, Liu MJ, Zou LP. Rapamycin/Sirolimus Improves the Behavior of an 8-Year-Old Boy With Nonsyndromic Autism Spectrum Disorder. Am J Ther. 2020 Feb 20;28(5):e608-e610. doi: 10.1097/MJT.0000000000001131. PMID: 34491961.

Hussein MH, Alameen AA, Ansari MA, AlSharari SD, Ahmad SF, Attia MSM, Sarawi WS, Nadeem A, Bakheet SA, Attia SM. Semaglutide ameliorated autism-like behaviors and DNA repair efficiency in male BTBR mice by recovering DNA repair gene expression. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Dec 20;135:111091. doi: 10.1016/j.pnpbp.2024.111091. Epub 2024 Jul 18. PMID: 39032854.

Yang MJ, Jia M, Cai M, Feng X, Huang LN, Yang JJ. Central neuropeptides as key modulators of astrocyte function in neurodegenerative and neuropsychiatric disorders. Psychopharmacology (Berl). 2025 Jun 19. doi: 10.1007/s00213-025-06840-9. Epub ahead of print. PMID: 40536717.)

Huang H, Weng H, Zhou K, Wu T, Zhao BS, Sun M, Chen Z, Deng X, Xiao G, Auer F, Klemm L, Wu H, Zuo Z, Qin X, Dong Y, Zhou Y, Qin H, Tao S, Du J, Liu J, Lu Z, Yin H, Mesquita A, Yuan CL, Hu YC, Sun W, Su R, Dong L, Shen C, Li C, Qing Y, Jiang X, Wu X, Sun M, Guan JL, Qu L, Wei M, Müschen M, Huang G, He C, Yang J, Chen J. Histone H3 trimethylation at lysine 36 guides m6A RNA modification co- transcriptionally. Nature. 2019 Mar;567(7748):414-419. doi: 10.1038/s41586-019- 1016-7. Epub 2019 Mar 13. PMID: 30867593; PMCID: PMC6438714.

Okazaki S, Kimura R, Otsuka I, Funabiki Y, Murai T, Hishimoto A. Epigenetic clock analysis and increased plasminogen activator inhibitor-1 in high-functioning autism spectrum disorder. PLoS One. 2022 Feb 3;17(2):e0263478. doi: 10.1371/journal.pone.0263478. PMID: 35113965; PMCID: PMC8812940.

Nardone S, Sams DS, Reuveni E, Getselter D, Oron O, Karpuj M, Elliott E. DNA methylation analysis of the autistic brain reveals multiple dysregulated biological pathways. Transl Psychiatry. 2014 Sep 2;4(9):e433. doi: 10.1038/tp.2014.70. PMID: 25180572; PMCID: PMC4203003.

Ramaswami G, Won H, Gandal MJ, Haney J, Wang JC, Wong CCY, Sun W, Prabhakar S, Mill J, Geschwind DH. Integrative genomics identifies a convergent molecular subtype that links epigenomic with transcriptomic differences in autism. Nat Commun. 2020 Sep 25;11(1):4873. doi: 10.1038/s41467-020-18526-1. PMID: 32978376; PMCID: PMC7519165.

Schmidt RJ, Iosif AM, Guerrero Angel E, Ozonoff S. Association of Maternal Prenatal Vitamin Use With Risk for Autism Spectrum Disorder Recurrence in Young Siblings.

JAMA Psychiatry. 2019 Apr 1;76(4):391-398. doi: 10.1001/jamapsychiatry.2018.3901. PMID: 30810722; PMCID: PMC6450282.

Avram OE, Bratu EA, Curis C, Moroianu LA, Drima E. Modifiable Nutritional Biomarkers in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis of Vitamin D, B12, and Homocysteine Exposure Spanning Prenatal Development Through Late Adolescence. Int J Mol Sci. 2025 May 6;26(9):4410. doi: 10.3390/ijms26094410. PMID: 40362647; PMCID: PMC12072606.

De Marzio M, Lasky-Su J, Chu SH, Prince N, Litonjua AA, Weiss ST, Kelly RS, Glass KR. The metabolic role of vitamin D in children's neurodevelopment: a network study. Sci Rep. 2024 Jul 23;14(1):16929. doi: 10.1038/s41598-024-67835-8. PMID: 39043876; PMCID: PMC11266698.

Frye RE, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, Hubanks A, Gaylor DW, Walters L, James SJ. Effectiveness of methylcobalamin and folinic Acid treatment on adaptive behavior in children with autistic disorder is related to glutathione redox status. Autism Res Treat. 2013;2013:609705. doi: 10.1155/2013/609705. Epub 2013 Oct 12. PMID: 24224089; PMCID: PMC3810468.

Hardan AY, Fung LK, Libove RA, Obukhanych TV, Nair S, Herzenberg LA, Frazier TW, Tirouvanziam R. A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. Biol Psychiatry. 2012 Jun 1;71(11):956-61. doi: 10.1016/j.biopsych.2012.01.014. Epub 2012 Feb 18. PMID: 22342106; PMCID: PMC4914359.

Adams JB, Bhargava A, Coleman DM, Frye RE, Rossignol DA. Ratings of the Effectiveness of Nutraceuticals for Autism Spectrum Disorders: Results of a National Survey. J Pers Med. 2021 Aug 31;11(9):878. doi: 10.3390/jpm11090878. PMID: 34575655; PMCID: PMC8470413.